S&P 500 7,580.07 −1.82%
Nasdaq 25,437.00 −2.86%
S&P/TSX 35,620.03 −1.74%
Apple 344.63 −1.23%
Nvidia 204.64 −4.22%
Microsoft 521.91 −1.55%
Shopify 220.37 −5.70%
Royal Bank 283.93 −1.49%
CAD/USD 0.7158 +0.11%
CLOSED · 09:30 ET
Market ClerkRecap
Sun Nov 1 · markets closed1 signal on Oct 31129 insider buys this week · $10BCIRO short report next: Nov 15The week ahead

HBIO

HARVARD BIOSCIENCE INC
NASDAQ · TECHNOLOGY · LABORATORY ANALYTICAL INSTRUMENTS
8.90
+0.10 +1.14%
USD · close Oct 30

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $40.5MP/E —DIV YIELD —FCF YIELD -2.76%REV TTM $87.8M −1.1%NET INCOME −$10.4MNET DEBT $30.2M52W 4.31 – 8.90SEC XBRL · TTM TO Invalid Date

Who holds it

SEC 13F · LATEST QUARTER PER FUND
None of the 15 tracked funds disclose HBIO in their latest 13F. The funds we follow.

13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.

Stakes of 5% or more

SCHEDULE 13D / 13G · LATEST PER HOLDER · TWO YEARS
Leviticus Partners LP5.2%
SCHEDULE 13G/A · filed Sep 22 · passive · EDGAR ↗

A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.

Watch HBIO. Know when insiders buy.
One email the day a filing lands. Free.